{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:09:19Z","timestamp":1775815759381,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s10875-008-9253-9","type":"journal-article","created":{"date-parts":[[2008,9,30]],"date-time":"2008-09-30T12:23:21Z","timestamp":1222777401000},"page":"238-245","source":"Crossref","is-referenced-by-count":33,"title":["Chinese Patients with Defective IL-12\/23-Interferon-\u03b3 Circuit in Taiwan: Partial Dominant Interferon-\u03b3 Receptor 1 Mutation Presenting as Cutaneous Granuloma and IL-12 Receptor \u03b21 Mutation as Pneumatocele"],"prefix":"10.1007","volume":"29","author":[{"given":"Wen-I","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzou-Yien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuen","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Ying","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang-Her","family":"Jaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,1]]},"reference":[{"key":"9253_CR1","first-page":"298","volume-title":"Cellular and molecular immunology","author":"AK Abbas","year":"2003","unstructured":"Abbas AK, Lichtman AH. Effector mechanisms of cell-mediated immunity. In: Abbas AK, Lichtman AH, editors. Cellular and molecular immunology. 5th ed. PA: Saunders; 2003. p. 298\u2013317.","edition":"5"},{"key":"9253_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","volume":"20","author":"JL Casanova","year":"2002","unstructured":"Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002;20:581\u2013620. doi: 10.1146\/annurev.immunol.20.081501.125851 .","journal-title":"Annu Rev Immunol"},{"key":"9253_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1359-6101(00)00010-1","volume":"11","author":"SE Dorman","year":"2000","unstructured":"Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11:321\u201333. doi: 10.1016\/S1359-6101(00)00010-1 .","journal-title":"Cytokine Growth Factor Rev"},{"key":"9253_CR4","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","volume":"364","author":"SE Dorman","year":"2004","unstructured":"Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004;364:2113\u201321. doi: 10.1016\/S0140-6736(04)17552-1 .","journal-title":"Lancet"},{"key":"9253_CR5","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1172\/JCI2901","volume":"101","author":"SE Dorman","year":"1998","unstructured":"Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998;101:2364\u20139. doi: 10.1172\/JCI2901 .","journal-title":"J Clin Invest"},{"key":"9253_CR6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/338625","volume":"70","author":"C Picard","year":"2002","unstructured":"Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002;70:336\u201348. doi: 10.1086\/338625 .","journal-title":"Am J Hum Genet"},{"key":"9253_CR7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.20021769","volume":"197","author":"C Fieschi","year":"2003","unstructured":"Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 2003;197:527\u201335. doi: 10.1084\/jem.20021769 .","journal-title":"J Exp Med"},{"key":"9253_CR8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1061154","volume":"293","author":"S Dupuis","year":"2001","unstructured":"Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, Harris J, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001;293:300\u20133. doi: 10.1126\/science.1061154 .","journal-title":"Science"},{"key":"9253_CR9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.20060085","volume":"203","author":"O Filipe-Santos","year":"2006","unstructured":"Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, et al. X-linked susceptibility to mycobacteria is caused by mutations in the NEMO leucine zipper domain that impair CD40-dependent IL-12 production. J Exp Med 2006;203:1745\u201359. doi: 10.1084\/jem.20060085 .","journal-title":"J Exp Med"},{"key":"9253_CR10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","volume":"18","author":"O Filipe-Santos","year":"2006","unstructured":"Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, et al. Inborn errors of IL-12\/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006;18:347\u201361. doi: 10.1016\/j.smim.2006.07.010 .","journal-title":"Semin Immunol"},{"key":"9253_CR11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698\u2013702. doi: 10.1001\/jama.271.9.698 .","journal-title":"JAMA"},{"key":"9253_CR12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s10875-006-9013-7","volume":"26","author":"WI Lee","year":"2006","unstructured":"Lee WI, Jaing TH, Hsieh MY, Kuo ML, Lin SJ, Huang JL. , infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan. J Clin Immunol 2006;26:274\u201383. doi: 10.1007\/s10875-006-9013-7 .","journal-title":"J Clin Immunol"},{"key":"9253_CR13","first-page":"3","volume":"49","author":"FC Liang","year":"2008","unstructured":"Liang FC, Wei YC, Jiang TH, Hsieh MY, Wen YC, Chiou YS, et al. Current classification and status of primary immunodeficiency diseases in Taiwan. Acta Paediatr Taiwan 2008;49:3\u20138.","journal-title":"Acta Paediatr Taiwan"},{"key":"9253_CR14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/499953","volume":"42","author":"AC Hesseling","year":"2006","unstructured":"Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, et al. Bacille Calmette\u2013Guerin vaccine-induced disease in HIV-infected and HIV infected children. Clin Infect Dis 2006;42:548\u201358. doi: 10.1086\/499953 .","journal-title":"Clin Infect Dis"},{"key":"9253_CR15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2003-12-4420","volume":"105","author":"WI Lee","year":"2005","unstructured":"Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005;105:1881\u201390. doi: 10.1182\/blood-2003-12-4420 .","journal-title":"Blood"},{"key":"9253_CR16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/7701","volume":"21","author":"E Jouanguy","year":"1999","unstructured":"Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondan\u00e8che MC, Dupuis S, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999;21:370\u20138. doi: 10.1038\/7701 .","journal-title":"Nat Genet"},{"key":"9253_CR17","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1002\/eji.200526258","volume":"35","author":"HR Yu","year":"2005","unstructured":"Yu HR, Chen RF, Hong KC, Bong CN, Lee WI, Kuo HC, et al. IL-12-independent Th1 polarization in human mononuclear cells infected with varicella-zoster virus. Eur J Immunol 2005;35:3664\u201372. doi: 10.1002\/eji.200526258 .","journal-title":"Eur J Immunol"},{"key":"9253_CR18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(95)91421-8","volume":"346","author":"JL Casanova","year":"1995","unstructured":"Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet 1995;346:581. doi: 10.1016\/S0140-6736(95)91421-8 .","journal-title":"Lancet"},{"key":"9253_CR19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","volume":"24","author":"EA Talbot","year":"1997","unstructured":"Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated bacilli Calmette\u2013Guerin disease after vaccination: case report and review. Clin Infect Dis 1997;24:1139\u201346. doi: 10.1086\/513642 .","journal-title":"Clin Infect Dis"},{"key":"9253_CR20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00130832-200112000-00003","volume":"1","author":"J Reichenbach","year":"2001","unstructured":"Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2001;1:503\u201311. doi: 10.1097\/00130832-200112000-00003 .","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9253_CR21","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jaci.2004.08.047","volume":"114","author":"T Niehues","year":"2004","unstructured":"Niehues T, Reichenbach J, Neubert J, Gudowius S, Puel A, Horneff G, et al. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol 2004;114:1456\u201362. doi: 10.1016\/j.jaci.2004.08.047 .","journal-title":"J Allergy Clin Immunol"},{"key":"9253_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaci.2007.04.034","volume":"120","author":"J Bustamante","year":"2007","unstructured":"Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol 2007;120:32\u20138. doi: 10.1016\/j.jaci.2007.04.034 .","journal-title":"J Allergy Clin Immunol"},{"key":"9253_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155\u201369. doi: 10.1097\/00005792-200005000-00003 .","journal-title":"Medicine (Baltimore)"},{"key":"9253_CR24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","volume":"25","author":"Y Minegishi","year":"2006","unstructured":"Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006;25:745\u201355. doi: 10.1016\/j.immuni.2006.09.009 .","journal-title":"Immunity"},{"key":"9253_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2003.12.001","volume":"16","author":"BM Babior","year":"2004","unstructured":"Babior BM. NADPH oxidase. Curr Opin Immunol 2004;16:42\u20137. doi: 10.1016\/j.coi.2003.12.001 .","journal-title":"Curr Opin Immunol"},{"key":"9253_CR26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/INF.0b013e31815b494c","volume":"27","author":"PP Lee","year":"2008","unstructured":"Lee PP, Chan KW, Jiang L, Chen T, Li C, Lee TL, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living a region endemic for tuberculosis. Pediatr Infect Dis J 2008;27:224\u201330.","journal-title":"Pediatr Infect Dis J"},{"key":"9253_CR27","first-page":"525","volume-title":"Primary immunodeficiency diseases","author":"D Roos","year":"2007","unstructured":"Roos D, Kijpers TW, Curnutte JT. Chronic granulomatous disease. In: Ochs HD, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases. 2nd ed. NY: Oxford; 2007. p. 525\u201349.","edition":"2"},{"key":"9253_CR28","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","volume":"120","author":"RS Geha","year":"2007","unstructured":"Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, et al. International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee: International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007;120:776\u201394. doi: 10.1016\/j.jaci.2007.08.053 .","journal-title":"J Allergy Clin Immunol"},{"key":"9253_CR29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/tropej\/fml001","volume":"52","author":"M Ozen","year":"2006","unstructured":"Ozen M, Ceyhan M, Sanal O, Bayraktar M, Mesci L. Recurrent Salmonella bacteremia in interleukin-12 receptor beta1 deficiency. J Trop Pediatr 2006;52:296\u20138. doi: 10.1093\/tropej\/fml001 .","journal-title":"J Trop Pediatr"},{"key":"9253_CR30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jpeds.2004.08.021","volume":"145","author":"J Roesler","year":"2004","unstructured":"Roesler J, Horwitz ME, Picard C, Bordigoni P, Davies G, Koscielniak E, et al. Hematopoietic stem cell transplantation for complete IFNgamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 2004;145:806\u201312. doi: 10.1016\/j.jpeds.2004.08.021 .","journal-title":"J Pediatr"},{"key":"9253_CR31","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1182\/blood-2003-04-1268","volume":"102","author":"ME Horwitz","year":"2003","unstructured":"Horwitz ME, Uzel G, Linton GF, Miller JA, Brown MR, Malech HL, et al. Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferongamma receptor-1 deficiency. Blood 2003;102:2692\u20134. doi: 10.1182\/blood-2003-04-1268 .","journal-title":"Blood"},{"key":"9253_CR32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00431-007-0430-2","volume":"167","author":"PP Lee","year":"2008","unstructured":"Lee PP, Jiang LP, Wang XC, Chan KW, Tu WW, Lau YL. Severe mycobacterial infections in two pairs of Chinese siblings with interleukin-12 receptor beta1 deficiency. Eur J Pediatr 2008;167:231\u20132. doi: 10.1007\/s00431-007-0430-2 .","journal-title":"Eur J Pediatr"},{"key":"9253_CR33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-4632.2007.03365.x","volume":"46","author":"CC Zou","year":"2007","unstructured":"Zou CC, Zhao ZY. Clinical and molecular analysis of NF-kappa B essential modulator in Chinese incontinentia pigmenti patients. Int J Dermatol 2007;46:1017\u201322. doi: 10.1111\/j.1365-4632.2007.03365.x .","journal-title":"Int J Dermatol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9253-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-008-9253-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9253-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:10:05Z","timestamp":1559261405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-008-9253-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["9253"],"URL":"https:\/\/doi.org\/10.1007\/s10875-008-9253-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}